MR
Marker Therapeutics, Inc.
MRKR · NASDAQ
$1.18 -0.84% (-$0.01)
1M -15.11%
Market Cap $19.7M
P/E Ratio -
Div. Yield -
ROE 56.96%
Bulios Fair Price
$1.27
7.6% upside
Trenutna cena
$1.18
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MRKR trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
49 /100
Fair P/S 15.96x
P/B 1.62x
P/E N/A
Growth
0 /100
Declining Book val. growth 5.02%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 320.83%
FCF margin 791.32%
Net margin 706.23%
Quality
1 /100
Poor ROIC 87.91%
Asset turnover 0.08x
ROE 56.96%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 6.03x
Int. coverage N/A
Stability
39 /100
Moderate Beta 1.53x
Profitable years 0
Rev. volatility 99.58%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MRKR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Juan F. Vera
Employees
5
Headquarters
Houston
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report